If this box remains here for more than 30 seconds, click this link to try again.
Products & Services ╗
Best Practice Database
Market Research, Analytics and Forecasting ╗ Analytics
Download FREE Excerpt
19 Info Graphics
13 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The 21st century has seen an explosion in the availability of all types of data, including healthcare, social media and transactional information. Together, these and other types of large and complex data sets have come to be known as Big Data. The influence of big data within the pharmaceutical industry is still emerging for organizations facing key medical, commercial, and HEOR decisions.
It is important for biopharmaceutical companies attempting to utilize Big Data in their decision-making to not only understand the most valuable data producers but also the most impactful way to disseminate Big Data analyses. This study presents benchmark data on these questions as well as who are the most frequent internal requestors of Big Data analysis and the presence of a Big Data team or function within benchmark participants. Best Practices, LLC utilized medical, commercial and HEOR segmented responses to investigate these issues. The study offers key benchmarks that will help leaders to better understand the growing influence of Big Data in the biopharmaceutical sector and how it impacts medical, HEOR and commercial operations in the U.S.
This study provides Medical, Commercial and HEOR segmented responses on survey questions.
Pharmaceutical; Health Care; Biotech; Chemical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Biopharmaceutical; Clinical Research; Laboratories
Merck; Merck Serono; Novartis; Boehringer Ingelheim; Genentech; Teva Pharmaceutical Industries Ltd; Pfizer; Baxter Healthcare; GlaxoSmithKline ; Bayer; Gilead Sciences; Janssen; Lundbeck; Sanofi; Esteve; Daiichi Sankyo; Purdue Pharma; AstraZeneca
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.